acetaminophen has been researched along with cyclosporine in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (10.64) | 18.2507 |
2000's | 17 (36.17) | 29.6817 |
2010's | 22 (46.81) | 24.3611 |
2020's | 3 (6.38) | 2.80 |
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beales, D; McLean, AE | 1 |
Kim, MS; Kim, SI; Kim, YS; Oh, CK; Park, K | 1 |
Baker, P; Bensen, W; Gent, M; Grace, E; Ludwin, D; Roberts, R; Tugwell, P | 1 |
Curti, C; Mingatto, FE; Pigoso, AA; Rodrigues, T; Santos, AC; Uyemura, SA | 1 |
Hoshino, N; Minouchi, T; Ohmae, T; Shibata, N; Yamaji, A | 1 |
Chojnowski, K; Góra-Tybor, J; Robak, E; Robak, T; Strzelecka, B; Sysa-Jedrzejowska, A; Waszczykowska, E | 1 |
Damato, R; Di Poi, E; Favret, G; Ferraccioli, GF; Gremese, E; Tomietto, P | 1 |
Hartung, T; Jennings, P; Koppelstaetter, C; Morin, JP; Pfaller, W; Ryan, MP | 1 |
Justo, P; Lorz, C; Marrón, B; Ortiz, A; Sanz, A | 1 |
Jaeschke, H; Kim, JS; Kon, K; Lemasters, JJ | 1 |
Horie, T; Masubuchi, Y; Suda, C | 1 |
Szegedi, J | 1 |
Aoyama, T; Arai, K; Ikejima, K; Kon, K; Lemasters, JJ; Okumura, K; Sato, N; Takei, Y | 1 |
Baken, KA; Breit, TM; de Vries, A; Jonker, MJ; Pennings, JL; Schaap, MM; van Loveren, H; van Steeg, H | 1 |
Azarpira, N; Baghban, M; Jamshidzadeh, A; Mohammadi Bardbori, A; Niknahad, H | 1 |
Inoue, D; Kimura, T; Kurata, M; Maruoka, H; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Shimoji, S; Tabata, S; Takahashi, T; Yamashita, E | 1 |
Förger, F; Østensen, M | 1 |
Bouwman, FG; Kleinjans, JC; Mariman, EC; Noben, JP; Renes, J; van Delft, JH; Van Summeren, A | 1 |
Chaudhuri, S; Hennings, L; Hinson, JA; James, LP; Letzig, L; McCullough, SS; Simpson, PM | 1 |
Gilson, R; Henning, JS; Ladd, D; Reese, D; Rockers, K | 1 |
Jaeschke, H; McGill, MR; Ramachandran, A | 1 |
Bouwman, FG; Kleinjans, JC; Lizarraga, D; Mariman, EC; Noben, JP; Renes, J; van Delft, JH; Van Summeren, A | 1 |
Abe, N; Aritomi, K; Irie, T; Irikura, M; Ishitsuka, Y; Kai, H; Shimizu, D; Shuto, T; Tomishima, Y | 1 |
Driessen, M; Kienhuis, AS; Pennings, JL; van der Ven, LT; Vitins, AP; Water, Bv | 1 |
Hu, J; Jaeschke, H; Lemasters, JJ; McGill, MR; Ramshesh, VK | 1 |
Gore, E; Groothuis, GM; Olinga, P; Pennings, JL; Vatakuti, S | 1 |
Nakamura, R; Saito, Y | 1 |
Reamy, BV; Servey, JT; Williams, PM | 1 |
Enver Ozan, İ; Erdem Güzel, E; Gül, M; Kavak Balgetir, M; Kaya Tektemur, N; Ozan Kocamüftüoğlu, G; Özcan Yıldırım, S; Tektemur, A; Yalçın, T | 1 |
Callegaro, G; den Hollander, W; Furlong, L; Grosdidier, S; Guney, E; Kunnen, SJ; Mollon, J; Niemeijer, M; Piñero Gonzalez, J; Saez-Rodriguez, J; Stevens, JL; Sutherland, JJ; Trairatphisan, P; van de Water, B; Webster, YW | 1 |
8 review(s) available for acetaminophen and cyclosporine
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New molecular mechanisms of nephrotoxicity].
Topics: Acetaminophen; Apoptosis; bcl-X Protein; Caspase 8; Caspases; Cyclosporine; Cysteine Proteinase Inhibitors; Cytokines; Endoplasmic Reticulum; Epithelium; fas Receptor; Humans; Kidney Diseases; Kidney Tubules; Mitochondria; Models, Biological; Proto-Oncogene Proteins c-bcl-2 | 2004 |
[Renal insufficiency caused by medicines, diagnostic processes, toxins].
Topics: Acetaminophen; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Cisplatin; Contrast Media; Cyclosporine; Foscarnet; Humans; Hungary; Ischemia; Kidney; Kidney Function Tests; Pentamidine; Prognosis | 2007 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
Cyclosporine for SJS/TEN: a case series and review of the literature.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Infective Agents; Anticonvulsants; Cyclosporine; Dermatologic Agents; Drug Combinations; Female; Humans; Lamotrigine; Male; Stevens-Johnson Syndrome; Sulfamethizole; Triazines; Trimethoprim | 2011 |
[Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy].
Topics: Acetaminophen; Adrenal Cortex Hormones; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Carbamazepine; CD8-Positive T-Lymphocytes; Cyclosporine; Epidermis; Etanercept; Fas Ligand Protein; HLA Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Japan; Lamotrigine; Plasma Exchange; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha | 2019 |
Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Child; Cyclosporine; Disease Progression; Glomerulonephritis; Humans; IgA Vasculitis; Immunosuppressive Agents; Mycophenolic Acid; Nephrology; Recurrence; Referral and Consultation; Remission, Spontaneous; Urinalysis | 2020 |
3 trial(s) available for acetaminophen and cyclosporine
Article | Year |
---|---|
Treatment of steroid resistant acute rejection after renal transplantation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antilymphocyte Serum; Cyclosporine; Diphenhydramine; Drug Resistance; Graft Rejection; Histamine H1 Antagonists; Humans; Hydrocortisone; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Muromonab-CD3; Recurrence | 1996 |
Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Creatinine; Cross-Over Studies; Cyclosporine; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Indomethacin; Ketoprofen; Male; Middle Aged; Treatment Outcome | 1997 |
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; HLA-DR1 Antigen; Humans; Male; Methotrexate; Middle Aged; Pain; Sulfasalazine | 2002 |
36 other study(ies) available for acetaminophen and cyclosporine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Protection in the late stages of paracetamol-induced liver cell injury with fructose, cyslosporin A and trifluoperazine.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Cell Death; Cyclosporine; Drug Combinations; Fructose; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Male; Membrane Potentials; Microtomy; Mitochondria, Liver; Rats; Rats, Wistar; Trifluoperazine | 1996 |
Influence of nonsteroidal anti-inflammatory drugs on calcium efflux in isolated rat renal cortex mitochondria and aspects of the mechanisms involved.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Cyclosporine; Diclofenac; Dipyrone; Ibuprofen; In Vitro Techniques; Ion Transport; Kidney Cortex; Male; Mefenamic Acid; Mitochondria; NAD; NADP; Oxidation-Reduction; Piroxicam; Rats; Rats, Wistar; Salicylic Acid | 1998 |
Influence of glycerol-induced acute renal failure on the pharmacokinetics of cyclosporin in rats.
Topics: Acetaminophen; Acute Kidney Injury; Administration, Oral; Analgesics, Non-Narcotic; Animals; Area Under Curve; Blood Urea Nitrogen; Creatine; Cyclosporine; Gastric Emptying; Glycerol; Ileum; Immunosuppressive Agents; In Vitro Techniques; Injections, Intravenous; Jejunum; Liver; Male; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anemia, Aplastic; Cyclosporine; Granulocyte Colony-Stimulating Factor; Humans; Male; Penicillin V; Penicillins; Severity of Illness Index; Stevens-Johnson Syndrome | 2001 |
Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: toxicological evaluation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animal Testing Alternatives; Animals; Cell Culture Techniques; Coloring Agents; Cyclosporine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Kidney Diseases; L-Lactate Dehydrogenase; LLC-PK1 Cells; Oxazines; Perfusion; Sodium Dodecyl Sulfate; Surface-Active Agents; Swine; Time Factors; Toxicity Tests, Chronic; Xanthenes | 2004 |
Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes.
Topics: Acetaminophen; Adenosine Triphosphate; Analgesics, Non-Narcotic; Animals; Apoptosis; Caspase 3; Caspases; Cell Death; Cells, Cultured; Cyclosporine; Drug Synergism; Fructose; Glycine; Hepatocytes; Immunosuppressive Agents; Ion Channels; Male; Mice; Mice, Inbred Strains; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Time Factors | 2004 |
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice.
Topics: Acetaminophen; Adenosine Triphosphate; Animals; Benzoquinones; Calcium; Cyclosporine; Glutathione Disulfide; Imines; Liver; Male; Membrane Potentials; Mice; Mitochondria, Liver; Permeability | 2005 |
Role of apoptosis in acetaminophen hepatotoxicity.
Topics: Acetaminophen; Animals; Apoptosis; Cell Membrane Permeability; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Mice; Microscopy, Confocal; Mitochondria, Liver; Necrosis; Oxidative Stress | 2007 |
Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening.
Topics: Acetaminophen; Animals; Benzo(a)pyrene; Body Weight; Cell Cycle; Cyclosporine; Gene Expression Profiling; Gene Expression Regulation; Immune System; Lymph Nodes; Male; Mice; Mice, Inbred C57BL; Spleen; Trialkyltin Compounds | 2008 |
Effects of tomato extract on oxidative stress induced toxicity in different organs of rats.
Topics: Acetaminophen; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Immunosuppressive Agents; Kidney Diseases; Lipid Peroxidation; Lung Diseases; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Solanum lycopersicum | 2008 |
[Angioimmunoblastic T-cell lymphoma complicated by recurrent drug-induced agranulocytosis].
Topics: Acetaminophen; Aged; Agranulocytosis; Analgesics, Non-Narcotic; Cyclosporine; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Recurrence | 2009 |
Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Topics: Acetaminophen; Amiodarone; Blotting, Western; Cell Survival; Chemical and Drug Induced Liver Injury; Cluster Analysis; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Electrophoresis, Gel, Two-Dimensional; Hep G2 Cells; Humans; Pharmaceutical Preparations; Protein Biosynthesis; Protein Processing, Post-Translational; Proteins; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry | 2011 |
Acetaminophen hepatotoxicity and HIF-1α induction in acetaminophen toxicity in mice occurs without hypoxia.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Nitroimidazoles; Oxidative Stress; Statistics, Nonparametric | 2011 |
Pathophysiological relevance of proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Topics: Acetaminophen; Amiodarone; Chemical and Drug Induced Liver Injury; Cyclosporine; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Proteomics | 2011 |
Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.
Topics: Acetaminophen; Amiodarone; Animals; Cell Line; Cluster Analysis; Cyclosporine; Gene Expression Profiling; Gene Expression Regulation; Genomics; Hep G2 Cells; Hepatocytes; Humans; Male; Mice; Primary Cell Culture; Proteome; Proteomics | 2013 |
Evaluation of three-dimensional cultured HepG2 cells in a nano culture plate system: an in vitro human model of acetaminophen hepatotoxicity.
Topics: Acetaminophen; Acetylcysteine; Anthracenes; Cells, Cultured; Cyclosporine; Cytochrome P-450 CYP2E1; Drug Evaluation, Preclinical; Glutathione; Hep G2 Cells; Humans; Liver; MAP Kinase Kinase 4; Membrane Potential, Mitochondrial; Nanotechnology; Toxicity Tests | 2014 |
A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen.
Topics: Acetaminophen; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Cyclosporine; Embryo, Nonmammalian; Gene Expression; Hepatocytes; Humans; Immunosuppressive Agents; In Vitro Techniques; Mice; Mice, Inbred C57BL; Rats; Transcriptome; Zebrafish | 2015 |
Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria, Liver | 2016 |
Classification of Cholestatic and Necrotic Hepatotoxicants Using Transcriptomics on Human Precision-Cut Liver Slices.
Topics: Acetaminophen; Aged; Benzofurans; Bile Acids and Salts; Chloramphenicol; Chlorpromazine; Cholestasis; Colchicine; Cyclosporine; Diethylnitrosamine; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Gene Expression Profiling; Hepatocytes; Humans; Liver; Male; Methyltestosterone; Middle Aged; Necrosis; Phenotype; Toxicogenetics; Young Adult | 2016 |
The combination of N-acetylcysteine and cyclosporin A reduces acetaminophen-induced hepatotoxicity in mice.
Topics: Acetaminophen; Acetylcysteine; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Liver; Mice | 2021 |
The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Datasets as Topic; Endoplasmic Reticulum Stress; Gene Expression Profiling; Gene Regulatory Networks; Hepatocytes; Humans; Oxidative Stress; Rats; Risk Assessment; Species Specificity; Toxicogenetics; Tunicamycin | 2021 |